Business Association Chemistry Pharma Life Sciences

Position papers


No expansion to COVID-19 therapeutics and diagnostics

Show more

Would it make sense to manufacture more medication in Switzerland so as to exclude supply shortfalls? This is unfortunately neither practical nor efficient.

Show more

scienceindustries basically supports efforts to initiate and implement modernization negotiations for the existing Switzerland-Japan free trade agreement, but not at any price. scienceindustries strongly opposes an amendment to the procedure for origin examination analogous to the EU-Japan Free Trade Agreement.

Show more

For fundamental reasons, scienceindustries rejects the exclusion of products from negotiations for free trade agreements. Such exclusions not only contradict the spirit of free trade, but they are also diametrically opposed to the policy of comprehensive mutual market access for all trading partners.

Show more


Newsletter subscription

scienceindustries News


Foreign trade statistics chemistry pharma life science

Further analyzes

Export Chemicals Pharma Life Sciences Switzerland by region

Further analyzes